COSCIENS BIOPHARMA INC (CSCI) Stock Analyst Ratings
NASDAQ:CSCI - Nasdaq - CA22112H1010 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CSCI. The Buy consensus is the weighted average rating of the current analysts ratings.
CSCI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CSCI.
In the previous month the buy percentage consensus was at a similar level.
CSCI was analyzed by 7 analysts. More opinions would make the average more meaningful.